Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
13,253
archived clinical trials in
Arthritis

A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  4/2/2016
Clinical Research Facility
1065
mi
from 98109
San Diego, CA
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 4/2/2016
Clinical Research Facility
1065
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  4/2/2016
Clinical Research Facility
1070
mi
from 98109
Colorado Springs, CO
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 4/2/2016
Clinical Research Facility
1070
mi
from 98109
Colorado Springs, CO
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  4/2/2016
Clinical Research Facility
2724
mi
from 98109
Aventura, FL
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 4/2/2016
Clinical Research Facility
2724
mi
from 98109
Aventura, FL
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  4/2/2016
Clinical Research Facility
2708
mi
from 98109
Boca Raton, FL
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 4/2/2016
Clinical Research Facility
2708
mi
from 98109
Boca Raton, FL
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  4/2/2016
Clinical Research Facility
2717
mi
from 98109
Fort Lauderdale, FL
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 4/2/2016
Clinical Research Facility
2717
mi
from 98109
Fort Lauderdale, FL
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  4/2/2016
Clinical Research Facility
2513
mi
from 98109
Largo, FL
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 4/2/2016
Clinical Research Facility
2513
mi
from 98109
Largo, FL
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  4/2/2016
Clinical Research Facility
2730
mi
from 98109
South Miami, FL
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 4/2/2016
Clinical Research Facility
2730
mi
from 98109
South Miami, FL
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  4/2/2016
Clinical Research Facility
408
mi
from 98109
Boise, ID
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 4/2/2016
Clinical Research Facility
408
mi
from 98109
Boise, ID
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  4/2/2016
Clinical Research Facility
1733
mi
from 98109
Chicago, IL
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 4/2/2016
Clinical Research Facility
1733
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  4/2/2016
Clinical Research Facility
1867
mi
from 98109
Indianapolis, IN
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 4/2/2016
Clinical Research Facility
1867
mi
from 98109
Indianapolis, IN
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  4/2/2016
Clinical Research Facility
2485
mi
from 98109
Boston, MA
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 4/2/2016
Clinical Research Facility
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  4/2/2016
Clinical Research Facility
1393
mi
from 98109
Minneapolis, MN
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 4/2/2016
Clinical Research Facility
1393
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  4/2/2016
Clinical Research Facility
1720
mi
from 98109
Saint Louis, MO
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 4/2/2016
Clinical Research Facility
1720
mi
from 98109
Saint Louis, MO
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  4/2/2016
Clinical Research Facility
2392
mi
from 98109
Lebanon, NH
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 4/2/2016
Clinical Research Facility
2392
mi
from 98109
Lebanon, NH
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  4/2/2016
Clinical Research Facility
2385
mi
from 98109
Voorhees, NJ
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 4/2/2016
Clinical Research Facility
2385
mi
from 98109
Voorhees, NJ
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  4/2/2016
Clinical Research Facility
2412
mi
from 98109
Great Neck, NY
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 4/2/2016
Clinical Research Facility
2412
mi
from 98109
Great Neck, NY
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  4/2/2016
Clinical Research Facility
2428
mi
from 98109
Plainview, NY
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 4/2/2016
Clinical Research Facility
2428
mi
from 98109
Plainview, NY
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  4/2/2016
Clinical Research Facility
2161
mi
from 98109
Rochester, NY
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 4/2/2016
Clinical Research Facility
2161
mi
from 98109
Rochester, NY
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  4/2/2016
Clinical Research Facility
2434
mi
from 98109
Smithtown, NY
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 4/2/2016
Clinical Research Facility
2434
mi
from 98109
Smithtown, NY
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  4/2/2016
Clinical Research Facility
2426
mi
from 98109
Greenville, NC
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 4/2/2016
Clinical Research Facility
2426
mi
from 98109
Greenville, NC
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  4/2/2016
Clinical Research Facility
2279
mi
from 98109
Winston Salem, NC
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 4/2/2016
Clinical Research Facility
2279
mi
from 98109
Winston Salem, NC
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  4/2/2016
Clinical Research Facility
2029
mi
from 98109
Beachwood, OH
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 4/2/2016
Clinical Research Facility
2029
mi
from 98109
Beachwood, OH
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  4/2/2016
Clinical Research Facility
1961
mi
from 98109
Dayton, OH
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 4/2/2016
Clinical Research Facility
1961
mi
from 98109
Dayton, OH
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  4/2/2016
2031
mi
from 98109
Mayfield, OH
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 4/2/2016
2031
mi
from 98109
Mayfield, OH
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  4/2/2016
Clinical Research Facility
1565
mi
from 98109
Tulsa, OK
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 4/2/2016
Clinical Research Facility
1565
mi
from 98109
Tulsa, OK
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  4/2/2016
Clinical Research Facility
147
mi
from 98109
Portland, OR
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 4/2/2016
Clinical Research Facility
147
mi
from 98109
Portland, OR
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  4/2/2016
Clinical Research Facility
2205
mi
from 98109
Duncansville, PA
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 4/2/2016
Clinical Research Facility
2205
mi
from 98109
Duncansville, PA
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  4/2/2016
Clinical Research Facility
1682
mi
from 98109
Dallas, TX
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 4/2/2016
Clinical Research Facility
1682
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  4/2/2016
Clinical Research Facility
1890
mi
from 98109
Houston, TX
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 4/2/2016
Clinical Research Facility
1890
mi
from 98109
Houston, TX
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  4/2/2016
Clinical Research Facility
701
mi
from 98109
Salt Lake City, UT
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 4/2/2016
Clinical Research Facility
701
mi
from 98109
Salt Lake City, UT
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  4/2/2016
Clinical Research Facility
2
mi
from 98109
Seattle, WA
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 4/2/2016
Clinical Research Facility
2
mi
from 98109
Seattle, WA
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  4/2/2016
Clinical Research Facility
1684
mi
from 98109
Glendale, WI
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 4/2/2016
Clinical Research Facility
1684
mi
from 98109
Glendale, WI
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  4/2/2016
Clinical Research Facility
1560
mi
from 98109
Wausau, WI
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 4/2/2016
Clinical Research Facility
1560
mi
from 98109
Wausau, WI
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  4/2/2016
426
7320
mi
from 98109
Maroochydore,
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 4/2/2016
426
7320
mi
from 98109
Maroochydore,
Click here to add this to my saved trials
The Effects of Specialized Footwear in Osteoarthritis
The Effects of Specialized Footwear in Osteoarthritis
Status: Enrolling
Updated:  4/4/2016
Rush University Medical Center
1730
mi
from 98109
Chicago, IL
The Effects of Specialized Footwear in Osteoarthritis
The Effects of Specialized Footwear in Osteoarthritis
Status: Enrolling
Updated: 4/4/2016
Rush University Medical Center
1730
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Total Knee Replacement Study Using Standard Cutting Guide vs Otismed MRI Generated Cutting Guide
Total Knee Replacement Using Standard Knee Cutting Guides vs Otismed MRI Generated Cutting Guide
Status: Enrolling
Updated:  4/4/2016
Carl T. Hayden VA Medical Center
1112
mi
from 98109
Phoenix, AZ
Total Knee Replacement Study Using Standard Cutting Guide vs Otismed MRI Generated Cutting Guide
Total Knee Replacement Using Standard Knee Cutting Guides vs Otismed MRI Generated Cutting Guide
Status: Enrolling
Updated: 4/4/2016
Carl T. Hayden VA Medical Center
1112
mi
from 98109
Phoenix, AZ
Click here to add this to my saved trials
Total Knee Replacement Study Using Standard Cutting Guide vs Otismed MRI Generated Cutting Guide
Total Knee Replacement Using Standard Knee Cutting Guides vs Otismed MRI Generated Cutting Guide
Status: Enrolling
Updated:  4/4/2016
VA Salt Lake City Health Care System, Salt Lake City, UT
701
mi
from 98109
Salt Lake City, UT
Total Knee Replacement Study Using Standard Cutting Guide vs Otismed MRI Generated Cutting Guide
Total Knee Replacement Using Standard Knee Cutting Guides vs Otismed MRI Generated Cutting Guide
Status: Enrolling
Updated: 4/4/2016
VA Salt Lake City Health Care System, Salt Lake City, UT
701
mi
from 98109
Salt Lake City, UT
Click here to add this to my saved trials
Effects of Transcranial Direct Current Stimulation (tDCS) and Transcranial Ultrasound on Osteoarthritis Pain of the Knee
Effects of Transcranial Direct Current Stimulation and Transcranial Ultrasound on the Perception of Pain Due to Osteoarthritis of the Knee
Status: Enrolling
Updated:  4/5/2016
Spaulding Rehabilitation Hospital
2485
mi
from 98109
Boston, MA
Effects of Transcranial Direct Current Stimulation (tDCS) and Transcranial Ultrasound on Osteoarthritis Pain of the Knee
Effects of Transcranial Direct Current Stimulation and Transcranial Ultrasound on the Perception of Pain Due to Osteoarthritis of the Knee
Status: Enrolling
Updated: 4/5/2016
Spaulding Rehabilitation Hospital
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Sarilumab Effect on the Pharmacokinetics of Simvastatin
A Multi-center, Open-label, 2-treatment, Single-sequence Clinical Study to Evaluate the Effects of a Single 200 mg Subcutaneous Injection of Sarilumab on the Pharmacokinetics of a Single 40 mg Oral Dose of Simvastatin, With Optional 1-year Extension of Open Label Treatment of Sarilumab, in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  4/6/2016
Clinical Research Facility
2205
mi
from 98109
Duncansville, PA
Sarilumab Effect on the Pharmacokinetics of Simvastatin
A Multi-center, Open-label, 2-treatment, Single-sequence Clinical Study to Evaluate the Effects of a Single 200 mg Subcutaneous Injection of Sarilumab on the Pharmacokinetics of a Single 40 mg Oral Dose of Simvastatin, With Optional 1-year Extension of Open Label Treatment of Sarilumab, in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 4/6/2016
Clinical Research Facility
2205
mi
from 98109
Duncansville, PA
Click here to add this to my saved trials
Sarilumab Effect on the Pharmacokinetics of Simvastatin
A Multi-center, Open-label, 2-treatment, Single-sequence Clinical Study to Evaluate the Effects of a Single 200 mg Subcutaneous Injection of Sarilumab on the Pharmacokinetics of a Single 40 mg Oral Dose of Simvastatin, With Optional 1-year Extension of Open Label Treatment of Sarilumab, in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  4/6/2016
Clinical Research Facility
1897
mi
from 98109
Jackson, TN
Sarilumab Effect on the Pharmacokinetics of Simvastatin
A Multi-center, Open-label, 2-treatment, Single-sequence Clinical Study to Evaluate the Effects of a Single 200 mg Subcutaneous Injection of Sarilumab on the Pharmacokinetics of a Single 40 mg Oral Dose of Simvastatin, With Optional 1-year Extension of Open Label Treatment of Sarilumab, in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 4/6/2016
Clinical Research Facility
1897
mi
from 98109
Jackson, TN
Click here to add this to my saved trials
Sarilumab Effect on the Pharmacokinetics of Simvastatin
A Multi-center, Open-label, 2-treatment, Single-sequence Clinical Study to Evaluate the Effects of a Single 200 mg Subcutaneous Injection of Sarilumab on the Pharmacokinetics of a Single 40 mg Oral Dose of Simvastatin, With Optional 1-year Extension of Open Label Treatment of Sarilumab, in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  4/6/2016
Clinical Research Facility
1682
mi
from 98109
Dallas, TX
Sarilumab Effect on the Pharmacokinetics of Simvastatin
A Multi-center, Open-label, 2-treatment, Single-sequence Clinical Study to Evaluate the Effects of a Single 200 mg Subcutaneous Injection of Sarilumab on the Pharmacokinetics of a Single 40 mg Oral Dose of Simvastatin, With Optional 1-year Extension of Open Label Treatment of Sarilumab, in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 4/6/2016
Clinical Research Facility
1682
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
Sarilumab Effect on the Pharmacokinetics of Simvastatin
A Multi-center, Open-label, 2-treatment, Single-sequence Clinical Study to Evaluate the Effects of a Single 200 mg Subcutaneous Injection of Sarilumab on the Pharmacokinetics of a Single 40 mg Oral Dose of Simvastatin, With Optional 1-year Extension of Open Label Treatment of Sarilumab, in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  4/6/2016
6647
mi
from 98109
Seoul,
Sarilumab Effect on the Pharmacokinetics of Simvastatin
A Multi-center, Open-label, 2-treatment, Single-sequence Clinical Study to Evaluate the Effects of a Single 200 mg Subcutaneous Injection of Sarilumab on the Pharmacokinetics of a Single 40 mg Oral Dose of Simvastatin, With Optional 1-year Extension of Open Label Treatment of Sarilumab, in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 4/6/2016
6647
mi
from 98109
Seoul,
Click here to add this to my saved trials
β-RELIEVED - REsponse in Acute fLare and In prEVEntion of episoDes of Re-flare in Gout - Extension 3 (E3)
An Open-label Extension Study of CACZ885H2356E2 and CACZ885H2357E2 on the Treatment and Prevention of Gout Flares in Patients With Frequent Flares for Whom NSAIDs and/or Colchicine Are Contraindicated, Not Tolerated or Ineffective
Status: Enrolling
Updated:  4/11/2016
Novartis Investigative Site
1503
mi
from 98109
Overland Park, KA
β-RELIEVED - REsponse in Acute fLare and In prEVEntion of episoDes of Re-flare in Gout - Extension 3 (E3)
An Open-label Extension Study of CACZ885H2356E2 and CACZ885H2357E2 on the Treatment and Prevention of Gout Flares in Patients With Frequent Flares for Whom NSAIDs and/or Colchicine Are Contraindicated, Not Tolerated or Ineffective
Status: Enrolling
Updated: 4/11/2016
Novartis Investigative Site
1503
mi
from 98109
Overland Park, KA
Click here to add this to my saved trials
β-RELIEVED - REsponse in Acute fLare and In prEVEntion of episoDes of Re-flare in Gout - Extension 3 (E3)
An Open-label Extension Study of CACZ885H2356E2 and CACZ885H2357E2 on the Treatment and Prevention of Gout Flares in Patients With Frequent Flares for Whom NSAIDs and/or Colchicine Are Contraindicated, Not Tolerated or Ineffective
Status: Enrolling
Updated:  4/11/2016
Novartis Investigative Site
1359
mi
from 98109
Omaha, NE
β-RELIEVED - REsponse in Acute fLare and In prEVEntion of episoDes of Re-flare in Gout - Extension 3 (E3)
An Open-label Extension Study of CACZ885H2356E2 and CACZ885H2357E2 on the Treatment and Prevention of Gout Flares in Patients With Frequent Flares for Whom NSAIDs and/or Colchicine Are Contraindicated, Not Tolerated or Ineffective
Status: Enrolling
Updated: 4/11/2016
Novartis Investigative Site
1359
mi
from 98109
Omaha, NE
Click here to add this to my saved trials
β-RELIEVED - REsponse in Acute fLare and In prEVEntion of episoDes of Re-flare in Gout - Extension 3 (E3)
An Open-label Extension Study of CACZ885H2356E2 and CACZ885H2357E2 on the Treatment and Prevention of Gout Flares in Patients With Frequent Flares for Whom NSAIDs and/or Colchicine Are Contraindicated, Not Tolerated or Ineffective
Status: Enrolling
Updated:  4/11/2016
Novartis Investigative Site
2117
mi
from 98109
Anniston, AL
β-RELIEVED - REsponse in Acute fLare and In prEVEntion of episoDes of Re-flare in Gout - Extension 3 (E3)
An Open-label Extension Study of CACZ885H2356E2 and CACZ885H2357E2 on the Treatment and Prevention of Gout Flares in Patients With Frequent Flares for Whom NSAIDs and/or Colchicine Are Contraindicated, Not Tolerated or Ineffective
Status: Enrolling
Updated: 4/11/2016
Novartis Investigative Site
2117
mi
from 98109
Anniston, AL
Click here to add this to my saved trials
β-RELIEVED - REsponse in Acute fLare and In prEVEntion of episoDes of Re-flare in Gout - Extension 3 (E3)
An Open-label Extension Study of CACZ885H2356E2 and CACZ885H2357E2 on the Treatment and Prevention of Gout Flares in Patients With Frequent Flares for Whom NSAIDs and/or Colchicine Are Contraindicated, Not Tolerated or Ineffective
Status: Enrolling
Updated:  4/11/2016
Novartis Investigative Site
2151
mi
from 98109
Mobile, AL
β-RELIEVED - REsponse in Acute fLare and In prEVEntion of episoDes of Re-flare in Gout - Extension 3 (E3)
An Open-label Extension Study of CACZ885H2356E2 and CACZ885H2357E2 on the Treatment and Prevention of Gout Flares in Patients With Frequent Flares for Whom NSAIDs and/or Colchicine Are Contraindicated, Not Tolerated or Ineffective
Status: Enrolling
Updated: 4/11/2016
Novartis Investigative Site
2151
mi
from 98109
Mobile, AL
Click here to add this to my saved trials
β-RELIEVED - REsponse in Acute fLare and In prEVEntion of episoDes of Re-flare in Gout - Extension 3 (E3)
An Open-label Extension Study of CACZ885H2356E2 and CACZ885H2357E2 on the Treatment and Prevention of Gout Flares in Patients With Frequent Flares for Whom NSAIDs and/or Colchicine Are Contraindicated, Not Tolerated or Ineffective
Status: Enrolling
Updated:  4/11/2016
Novartis Investigative Site
974
mi
from 98109
Norwalk, CA
β-RELIEVED - REsponse in Acute fLare and In prEVEntion of episoDes of Re-flare in Gout - Extension 3 (E3)
An Open-label Extension Study of CACZ885H2356E2 and CACZ885H2357E2 on the Treatment and Prevention of Gout Flares in Patients With Frequent Flares for Whom NSAIDs and/or Colchicine Are Contraindicated, Not Tolerated or Ineffective
Status: Enrolling
Updated: 4/11/2016
Novartis Investigative Site
974
mi
from 98109
Norwalk, CA
Click here to add this to my saved trials
β-RELIEVED - REsponse in Acute fLare and In prEVEntion of episoDes of Re-flare in Gout - Extension 3 (E3)
An Open-label Extension Study of CACZ885H2356E2 and CACZ885H2357E2 on the Treatment and Prevention of Gout Flares in Patients With Frequent Flares for Whom NSAIDs and/or Colchicine Are Contraindicated, Not Tolerated or Ineffective
Status: Enrolling
Updated:  4/11/2016
Novartis Investigative Site
957
mi
from 98109
Pasadena, CA
β-RELIEVED - REsponse in Acute fLare and In prEVEntion of episoDes of Re-flare in Gout - Extension 3 (E3)
An Open-label Extension Study of CACZ885H2356E2 and CACZ885H2357E2 on the Treatment and Prevention of Gout Flares in Patients With Frequent Flares for Whom NSAIDs and/or Colchicine Are Contraindicated, Not Tolerated or Ineffective
Status: Enrolling
Updated: 4/11/2016
Novartis Investigative Site
957
mi
from 98109
Pasadena, CA
Click here to add this to my saved trials
β-RELIEVED - REsponse in Acute fLare and In prEVEntion of episoDes of Re-flare in Gout - Extension 3 (E3)
An Open-label Extension Study of CACZ885H2356E2 and CACZ885H2357E2 on the Treatment and Prevention of Gout Flares in Patients With Frequent Flares for Whom NSAIDs and/or Colchicine Are Contraindicated, Not Tolerated or Ineffective
Status: Enrolling
Updated:  4/11/2016
Novartis Investigative Site
1059
mi
from 98109
San Diego, CA
β-RELIEVED - REsponse in Acute fLare and In prEVEntion of episoDes of Re-flare in Gout - Extension 3 (E3)
An Open-label Extension Study of CACZ885H2356E2 and CACZ885H2357E2 on the Treatment and Prevention of Gout Flares in Patients With Frequent Flares for Whom NSAIDs and/or Colchicine Are Contraindicated, Not Tolerated or Ineffective
Status: Enrolling
Updated: 4/11/2016
Novartis Investigative Site
1059
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
β-RELIEVED - REsponse in Acute fLare and In prEVEntion of episoDes of Re-flare in Gout - Extension 3 (E3)
An Open-label Extension Study of CACZ885H2356E2 and CACZ885H2357E2 on the Treatment and Prevention of Gout Flares in Patients With Frequent Flares for Whom NSAIDs and/or Colchicine Are Contraindicated, Not Tolerated or Ineffective
Status: Enrolling
Updated:  4/11/2016
Novartis Investigative Site
988
mi
from 98109
Tustin, CA
β-RELIEVED - REsponse in Acute fLare and In prEVEntion of episoDes of Re-flare in Gout - Extension 3 (E3)
An Open-label Extension Study of CACZ885H2356E2 and CACZ885H2357E2 on the Treatment and Prevention of Gout Flares in Patients With Frequent Flares for Whom NSAIDs and/or Colchicine Are Contraindicated, Not Tolerated or Ineffective
Status: Enrolling
Updated: 4/11/2016
Novartis Investigative Site
988
mi
from 98109
Tustin, CA
Click here to add this to my saved trials